These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17062669)

  • 1. The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.
    D'Arcy V; Abdullaev ZK; Pore N; Docquier F; Torrano V; Chernukhin I; Smart M; Farrar D; Metodiev M; Fernandez N; Richard C; Delgado MD; Lobanenkov V; Klenova E
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5978-86. PubMed ID: 17062669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.
    D'Arcy V; Pore N; Docquier F; Abdullaev ZK; Chernukhin I; Kita GX; Rai S; Smart M; Farrar D; Pack S; Lobanenkov V; Klenova E
    Br J Cancer; 2008 Feb; 98(3):571-9. PubMed ID: 18195709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.
    El-Sharkawy NM; Radwan WM; Essa ES; Kandeel EZ; Abd El-Fattah EK; Kandil SH; Kamel AM
    Cytometry B Clin Cytom; 2017 Sep; 92(5):355-360. PubMed ID: 27219508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.
    Chen K; Huang W; Huang B; Wei Y; Li B; Ge Y; Qin Y
    Genet Test Mol Biomarkers; 2013 Feb; 17(2):160-5. PubMed ID: 23237599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.
    Akhtar MS; Akhter N; Talat A; Alharbi RA; Sindi AAA; Klufah F; Alyahyawi HE; Alruwetei A; Ahmad A; Zamzami MA; Deo S; Husain SA; Badi OA; Khan MJ
    Oncotarget; 2023 May; 14():528-541. PubMed ID: 37235839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the cancer-testis antigen BORIS correlates with prostate cancer.
    Cheema Z; Hari-Gupta Y; Kita GX; Farrar D; Seddon I; Corr J; Klenova E
    Prostate; 2014 Feb; 74(2):164-76. PubMed ID: 24123052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases.
    Joosse SA; Müller V; Steinbach B; Pantel K; Schwarzenbach H
    Br J Cancer; 2014 Aug; 111(5):909-17. PubMed ID: 24983365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.
    Okabayashi K; Fujita T; Miyazaki J; Okada T; Iwata T; Hirao N; Noji S; Tsukamoto N; Goshima N; Hasegawa H; Takeuchi H; Ueda M; Kitagawa Y; Kawakami Y
    Cancer Sci; 2012 Sep; 103(9):1617-24. PubMed ID: 22676270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.
    Novak Kujundžić R; Grbeša I; Ivkić M; Krušlin B; Konjevoda P; Gall Trošelj K
    Pathol Oncol Res; 2014 Jul; 20(3):687-95. PubMed ID: 24563233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
    Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
    Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.
    Risinger JI; Chandramouli GV; Maxwell GL; Custer M; Pack S; Loukinov D; Aprelikova O; Litzi T; Schrump DS; Murphy SK; Berchuck A; Lobanenkov V; Barrett JC
    Clin Cancer Res; 2007 Mar; 13(6):1713-9. PubMed ID: 17363524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
    Horibe R; Hirohashi Y; Asano T; Mariya T; Suzuki T; Takaya A; Saijo H; Shionoya Y; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Watanabe K; Atsuyama E; Toji S; Hirano H; Hasegawa T; Takahashi H; Sato N; Torigoe T
    PLoS One; 2017; 12(3):e0171460. PubMed ID: 28248963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
    Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
    PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.
    Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V
    Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter.
    Kosaka-Suzuki N; Suzuki T; Pugacheva EM; Vostrov AA; Morse HC; Loukinov D; Lobanenkov V
    J Biol Chem; 2011 Aug; 286(31):27378-88. PubMed ID: 21659515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of the monoclonal antibodies against human BORIS and the expression pattern of BORIS in normal and diseased human mammary tissues].
    Zhou XC; Song CJ; Wang X; Tian Y; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):353-5. PubMed ID: 17428394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of promoter methylation and polymorphic minisatellites of BORIS and lack of association with gastric cancer.
    Yoon SL; Roh YG; Lee SH; Kim SH; Kim MC; Kim SJ; Leem SH
    DNA Cell Biol; 2011 Sep; 30(9):691-8. PubMed ID: 21495859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors.
    Loukinov D; Anderson AL; Mkrtichyan M; Ghochikyan A; Rivero-Hinojosa S; Tucker J; Lobanenkov V; Agadjanyan MG; Nelson EL
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the brother of the regulator of imprinted sites gene in the sputum of patients with lung cancer.
    Lee HY; Kim JI; Cho SH; Ko TY; Kim HS; Park SD; Cho SR; Chang HK; Hwang GJ; Jung SB
    Korean J Thorac Cardiovasc Surg; 2014 Aug; 47(4):378-83. PubMed ID: 25207247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.